Drug establishmentActive, Registered FY2026FDA warning letter on file

Sichuan Deebio Pharmaceutical Co.,Ltd

Sichuan Deebio Pharmaceutical Co.,Ltd is an FDA-registered drug establishment (FEI 3011139911) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2023-09-08) was classified OAI. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Feb 5, 2024
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3011139911
Address
15 She, ,
Establishment type
Drug establishment
Products / operations
Active pharmaceutical ingredient (API) manufacturing
Registration status
Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file
Sep 8, 2023 · Official Action Indicated (OAI)
Form 483 observations
None on file

Questions

Is Sichuan Deebio Pharmaceutical Co.,Ltd registered with the FDA?

Yes. Sichuan Deebio Pharmaceutical Co.,Ltd is an FDA-registered drug establishment (FEI 3011139911) in . Its current registration status is Active, Registered FY2026.

Has Sichuan Deebio Pharmaceutical Co.,Ltd received an FDA warning letter?

Yes. FDA issued a warning letter to Sichuan Deebio Pharmaceutical Co.,Ltd; the most recent is dated Feb 5, 2024 (CGMP/Active Pharmaceutical Ingredient (API)/Adulterated).

What does Sichuan Deebio Pharmaceutical Co.,Ltd do?

Sichuan Deebio Pharmaceutical Co.,Ltd's FDA-registered operations are: Active pharmaceutical ingredient (API) manufacturing.

Related facilities

Source: FDA public data · status as of 2026-06-06

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.